Blog

News February 19, 2021

Iterion Therapeutics Lands $17M Series B

– Iterion Therapeutics, a venture-backed, clinical stage biotechnology company developing novel cancer therapeutics, has raised $17m in a Series B financing. – The round was led by Lumira Ventures, with the participation of existing investors, including Santé Ventures, as well as new investors Venture Investors, GPG Ventures, and Viva BioInnovator.